Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants

Exclusion Criteria

• •Previous vaccination with licensed or investigational pneumococcal vaccine.
• •Prior receipt of routine pediatric vaccines, with the exception of hepatitis B vaccine.
• •Previous receipt of \>1 dose of hepatitis B vaccine.
• •Prior hepatitis B vaccine must have been administered at age \<30 days.
• •Major known congenital malformation or serious chronic disorder.
• •Receipt of blood/plasma products or immunoglobulins.